Epidemiologist Erin Bowles, MPH, is looking at cancer and aging from many different perspectives. Her research brings new insight into breast cancer risk factors, treatment, and survivorship, while helping improve cancer care for patients and families.
Ms. Bowles received an R50 mid-career research award from the National Cancer Institute (NCI). This award is given to cancer researchers who have demonstrated successes and contributions to cancer researcher as a non-principal investigator. As a key member of two large cancer collaborations—the NCI's Breast Cancer Surveillance Consortium and the Health Care Systems Cancer Research Network (CRN)—Ms. Bowles has developed diverse expertise that includes reading mammograms for breast density and using administrative data to understand patterns of care in cancer treatment.
Her current work includes:
Ms. Bowles' experience working with large cancer cohorts has provided her with expertise in data collection and management for other subject areas. She is a co-investigator on the Adult Changes in Thought study team, and oversees their living laboratory and data sharing for aging research, along with an annual research symposium. Finally, she is a member of the Kaiser Permanente Research Affiliates Evidence-based Practice Center and has participated in systematic evidence reviews for the U.S. Preventive Services Task Force.
Breast cancer; colorectal cancer; multiple myeloma; thyroid cancer; pancreatic cancer; biostatistics; epidemiology; mammography; mammographic breast density; cancer treatment; cancer screening and surveillance; automated data collection; quality of care; medication use; care coordination; administrative data
Access to care; health disparities; health outcomes research; quality of life; measurement of change in health care systems; practice variation
Menopause; hormone replacement therapy (HRT); breast cancer
Cognitive health and dementia; biostatistics; epidemiology; medication use; cancer
Pharmacoepidemiology; observational study research methods; chemotherapy; radiation exposure
McTiernan A, Wang CY, Sorensen B, Xiao L, Buist DS, Aiello Bowles EJ, White E, Rossing MA, Potter J, Urban N. No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1524-30. PubMed
Abraham L, Geller BM, Yankaskas BC, Bowles EJ, Karliner LS, Taplin SH, Miglioretti DL. Accuracy of self-reported breast cancer among women undergoing mammography. Breast Cancer Res Treat. 2009;118(3):583-92. Epub 2009 Mar 20. PubMed
Yong M, Atkinson C, Newton KM, Aiello Bowles EJ, Stanczyk FZ, Westerlind KC, Holt VL, Schwartz SM, Leisenring WM, Lampe JW. Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control. 2009;20(7):1039-53. Epub 2009 Mar 12. PubMed
Geller BM, Bowles EJ, Sohng HY, Brenner RJ, Miglioretti DL, Carney PA, Elmore JG. Radiologists' performance and their enjoyment of interpreting screening mammograms. AJR Am J Roentgenol. 2009;192(2):361-9. PubMed
Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DS. Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(2):676-9. Epub 2009 Feb 3. PubMed
Bowles EJ, Tuzzio L, Ross T, Williams AE, Altschuler A, Ritzwoller DP, Nekhlyudov L. The trustworthiness of administrative health plan data in chemotherapy research. Clinical Medicine & Research. 2008 Dec 1;6(3-4):123.
There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones.
A Kaiser Permanente-led BCSC study is among the largest ever to evaluate adding MRI surveillance for breast cancer survivors.
Kaiser Permanente Washington has been part of the national Breast Cancer Surveillance Consortium since 1994. Learn about the Kaiser Permanente Washington Breast Cancer Surveillance Registry here.
HealthDay, Jul 24, 2019